LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Ultra-Realistic Implant Simulation Testing Launches
Legal & Regulatory and Reimbursement

Ultra-Realistic Implant Simulation Testing Launches

May 18, 2023 2 min read Premium comments

Advertisement

Ultra-Realistic Implant Simulation Testing Launches
Courtesy of OTW Broadcasting
Secondary#alfonsocloud#lifespans#medicaldevicetesting

A self-service, particle-based SaaS simulation platform has been launched for use in the orthopedic and spinal implant industry.

The online platform gives implant manufacturers the ability to design, conduct and perform ultra-realistic tests for orthopedic and spine devices including joint reconstruction, trauma, and spinal implants. The portal is called the Alfonso™ Cloud and it was created by the team at Lifespans, Ltd., a software company.

According to the company, Alfonso is the “world’s first simulation system capable of simulating the cracking and crushing of realistic trabecular bone structures.” It incorporates a “‘particle-based’ computer model of bone tissue and bonelike materials” and “can provide extremely accurate models of material damage, such as during the loading of porous 3D-printed devices or implant subsidence in bone and foam.”

To see a short video of Alfonso in action, here is a video from OTW Broadcasting: https://www.youtube.com/watch?v=9QiYi5IyfyE

Research and development teams can use the online portal to complete tests with “downloadable results available in 1-2 days.” According to Lifespans, companies can select from “a growing library of standard ASTM tests” and the testing models are “provided with validation data based on V&V 40 standards.”

OTW spoke with Sloan Kulper, Ph.D., the CEO and co-founder of Lifespans, about Alfonso. OTW asked Dr. Kulper about what tests are currently available. Dr. Kulper told OTW, “Right now we have validated models of ASTM F543 A3 (screw pull out from a variety of foam grades), F2077 (spinal spacer axial compression), and F2267 (spinal spacer subsidence in foam).”

Dr. Kulper also informed OTW that ASTM F1264 (IM nail bending) ) is being launched in May 2023. Dr. Kulper elaborated, “This will be followed by press fit, cadaveric bone, and dynamic testing in the coming months.”

OTW also had the chance to discuss custom tests with Dr. Kulper. Dr. Kulper explained, “In principle, we can turn around a model with a minor change from the standard within a few days. Complex models usually take at least a few weeks.”

Advertisement

Dr. Kulper continued, “For longer projects, we usually save our customers significant time overall, however, as there are fewer false starts resulting from physically prototyping and testing implant designs that don’t end up working. We have been creating custom models for the last 18 months and until now it has represented the majority of our business.”

Finally, Lifespans was part of Orthopedics This Week’s PITCH program. Here is a link to that video: https://www.youtube.com/watch?v=9QiYi5IyfyE

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy